Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Phys Ther ; 98(6): 503-509, 2018 06 01.
Artículo en Inglés | MEDLINE | ID: mdl-29361051

RESUMEN

Background and Purpose: Chest pain, a frequent complaint for seeking medical care, is often attributed to musculoskeletal pathology. Costochondritis is a common disorder presenting as chest pain. Initial physical therapist examination emphasizes red flag screening. Reexamination throughout the episode of care is critical, particularly when patients are not progressing and/or in the presence of complex pain presentations. The purpose of this case report is to describe the clinical reasoning process in the management of a patient referred to physical therapy with a medical diagnosis of costochondritis. Case Description: A 59-year-old woman presented with a 5-month history of left-sided chest pain that had progressed to include the cervical and shoulder regions. She reported multiple psychosocial stressors; a depression screen was positive. She reported a history of asthma and smoking and improvement in recent fatigue, coughing, dyspnea, and sweating. At the initial visit, shoulder, cervical, and thoracic active and passive range of motion and joint mobility testing reproduced her pain. Allodynia was present throughout the painful areas in the left upper quarter. Outcomes: The patient demonstrated improvement over 30 days (4 visits). On her fifth visit (day 35), she reported an exacerbation of her chest and upper extremity pain and noted increased fatigue, sweating, dyspnea, and loss of appetite. Even though her pain was again reproduced with musculoskeletal testing, the physical therapist contacted the patient's physician regarding the change in presentation. A subsequent chest computed tomography scan revealed a non-small cell lung adenocarcinoma. Discussion: Cancer can masquerade as a musculoskeletal condition. This case highlights the importance of screening, clinical reasoning, and communication throughout the episode of care, particularly in the presence of chronic pain and psychosocial stressors.


Asunto(s)
Carcinoma de Pulmón de Células no Pequeñas/complicaciones , Dolor en el Pecho/etiología , Neoplasias Pulmonares/complicaciones , Osteocondritis/etiología , Modalidades de Fisioterapia , Anciano de 80 o más Años , Carcinoma de Pulmón de Células no Pequeñas/diagnóstico por imagen , Dolor en el Pecho/rehabilitación , Diagnóstico Diferencial , Femenino , Humanos , Neoplasias Pulmonares/diagnóstico por imagen , Osteocondritis/rehabilitación
2.
Ann Thorac Surg ; 104(1): 145-152, 2017 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-28109570

RESUMEN

BACKGROUND: Controlling sternal pain after heart surgery is important to reduce the risk of postoperative complications, but pain is often undertreated because of contraindications and side effects of analgesic drugs. Recently, osteopathic manipulative treatment (OMT) was demonstrated to reduce pain in different clinical contexts, suggesting its potential utility after cardiac surgery. The aim of this open-label, controlled study is to assess whether OMT contributes to sternal pain relief and improves postoperative outcomes. METHODS: Eighty post-sternotomy adult inpatients were randomly allocated one to one to receive a standardized cardiorespiratory rehabilitation program alone (control group) or combined with OMT. Pain intensity and respiratory functional capacity were quantified by the Visual Analogue Scale score and by a standardized breathing test, at the start and end of rehabilitation. RESULTS: At the start of rehabilitation, the control group and the OMT group had similar Visual Analogue Scale median scores (controls 4, interquartile range [IQR]: 2 to 5; OMT 4, IQR: 3 to 5; p = not significant) and mean inspiratory volumes (controls 825 ± 381 mL; OMT 744 ± 291 mL; p = not significant). At the end of rehabilitation, the OMT group had a lower Visual Analogue Scale median score (controls 3, IQR: 2 to 4; OMT 1, IQR: 1 to 2; p < 0.01) and higher mean inspiratory volume (controls 1,400 ± 588 mL; OMT 1,781 ± 633 mL; p < 0.01). The analgesic drug intake was similar in the two groups. The hospitalization was shorter in the OMT group than in the control group (19.1 ± 4.8 versus 21.7 ± 6.3 days; p < 0.05). CONCLUSIONS: The combination of standard care with OMT is effective in inducing pain relief and functional recovery, and significantly improves the management of patients after heart surgery with sternotomy.


Asunto(s)
Procedimientos Quirúrgicos Cardíacos , Dolor en el Pecho/rehabilitación , Osteopatía/métodos , Dolor Postoperatorio/rehabilitación , Anciano , Dolor en el Pecho/diagnóstico , Femenino , Estudios de Seguimiento , Cardiopatías/cirugía , Humanos , Pacientes Internos , Masculino , Persona de Mediana Edad , Dimensión del Dolor , Dolor Postoperatorio/diagnóstico , Recuperación de la Función , Estudios Retrospectivos , Método Simple Ciego , Esternotomía/efectos adversos , Resultado del Tratamiento
3.
Rehabil Nurs ; 40(5): 294-304, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-24668661

RESUMEN

PURPOSE: The case study was to determine the effectiveness of tensegrity massage in a patient after mastectomy. DESIGN: Tensegrity massage was performed in a 50-year-old woman after mastectomy. The purpose of the massage was to normalize the tension of musculo-ligamento-fascial system in the chest, shoulder girdle, and back. METHODS: The patient was subjected to a series of six massage sessions, 45 minutes each, twice a week. FINDINGS: The applied massage therapy contributed to the reduction of the postoperative scar tenderness and painfulness, to the relaxation of the muscular tone within the shoulder girdle, and to the improvement of the patient's general feeling. CONCLUSIONS: Tensegrity massage is an effective therapy in the elimination of pain and abnormal tissue tension induced by extensive scarring after mastectomy. CLINICAL RELEVANCE: The presented massage procedure had a positive effect immediately after the therapy and after 1-month follow-up.


Asunto(s)
Masaje/métodos , Mastectomía/efectos adversos , Mastectomía/rehabilitación , Tono Muscular , Dolor Postoperatorio/etiología , Dolor Postoperatorio/rehabilitación , Enfermería en Rehabilitación/métodos , Dolor de Espalda/etiología , Dolor de Espalda/rehabilitación , Dolor en el Pecho/etiología , Dolor en el Pecho/rehabilitación , Femenino , Humanos , Persona de Mediana Edad , Dolor de Cintura Pélvica/etiología , Dolor de Cintura Pélvica/rehabilitación , Dolor de Hombro/etiología , Dolor de Hombro/rehabilitación , Resultado del Tratamiento
4.
Presse Med ; 43(9): 981-93, 2014 Sep.
Artículo en Francés | MEDLINE | ID: mdl-25153783

RESUMEN

Patients with pulmonary arterial hypertension (PAH) must be referred to expert centers (reference center and competences centers in the French PAH network). Despite progresses in the knowledge of PAH pathophysiology, it is still a devastating disease needing an aggressive approach of therapy to improve long-term outcomes. The target of current therapies is endothelial dysfunction of pulmonary arteries. Continuous intravenous infusion of epoprostenol remains the only recommended therapy for the most severe patients with PAH. If treatment goals are not met, a sequential combination therapy is recommended (i.e. combination of drugs targeting different dysfunctional pathways). Lung transplantation remains the only curative treatment of PAH.


Asunto(s)
Hipertensión Pulmonar/terapia , Algoritmos , Altitud , Anticoagulantes/uso terapéutico , Antihipertensivos/uso terapéutico , Tabique Interatrial/cirugía , Bloqueadores de los Canales de Calcio/uso terapéutico , Dolor en el Pecho/fisiopatología , Dolor en el Pecho/rehabilitación , Anticonceptivos Hormonales Orales , Contraindicaciones , Diuréticos/uso terapéutico , Quimioterapia Combinada , Disnea/fisiopatología , Disnea/rehabilitación , Antagonistas de los Receptores de Endotelina , Ejercicio Físico/fisiología , Fatiga/fisiopatología , Fatiga/rehabilitación , Femenino , Humanos , Hipertensión Pulmonar/fisiopatología , Trasplante de Pulmón , Terapia por Inhalación de Oxígeno , Inhibidores de Fosfodiesterasa 5/uso terapéutico , Embarazo , Inhibidores de Proteínas Quinasas/uso terapéutico , Síncope/fisiopatología , Síncope/rehabilitación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA